Independence Through Collaboration Between the UK and USA Life Science Sectors
When and how to expand their operations across the Atlantic, either UK to USA or vice versa, is a strategic decision that falls to most senior executives and their board members as companies grow. Whether expansion involves collaboration, M&A or setting up an independent presence understanding factors such as a guide to the local investment trends, employment laws, talent acquisition and governmental support available can determine the degree of success. Fortunately, there is a great depth of experience available in meeting this challenge in both the UK and USA.
Our evening session will highlight some of the practical and strategic support available in order to enable attendees to refine their own strategies and decision-making processes to enable success.
18.00 - Registration, tea & coffee
18.30 - Welcome
Ken Larkin, London Bioscience Innovation Centre
18.40 - Introduction from the Chair
Tony Jones, One Nucleus
18.45 - Keynote Address: Expanding the MSD Innovation Presence in London
Fiona Marshall, MSD
19.00 - Panel Discussion: Growing Your Trans-Atlantic Business
Our panel of expert practitioners, selected for their experience and insight into how to address some of the practical barriers faced in expanding a business into the US and operating across both markets, will discuss how to approach some of the challenges and what solutions and support is available.
-Claire Button, Fusion Biomed
-Joanne Farquhason, Foothold America
-Linda di Mario, Greater Irvine Chamber
-Fiona Marshall, MSD
19.40 - Closing Remarks
19.45 - Networking over drinks and canapes
21.00 - Close